Document ID: FDA-2010-N-0274-0002
Agency: fda
Document Type: Notice
Title: Oversight of Laboratory Developed Tests; Public Meeting; Change of Meeting Location
Posted Date: 2010-07-13T04:00Z

[Federal Register: July 13, 2010 (Volume 75, Number 133)]
[Notices]               
[Page 39954]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13jy10-86]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0274]

 
Oversight of Laboratory Developed Tests; Public Meeting; Change 
of Meeting Location

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a change 
in location for the upcoming public meeting entitled ``Oversight of 
Laboratory Developed Tests.'' A new address is given for those 
attending the public meeting.

DATES: The public meeting will be held on July 19 and 20, 2010, from 8 
a.m. to 5 p.m. each day.

ADDRESES: The public meeting will be held at The Marriott Inn & 
Conference Center, University of Maryland University College, 3501 
University Blvd. E, Hyattsville, MD 20783.

FOR FURTHER INFORMATION CONTACT: Katherine Serrano, Center for Devices 
and Radiological Health, Food and Drug Administration 10903 New 
Hampshire Ave., Bldg. 66., rm 5613, Silver Spring, MD 20993-0002, 301-
796-6652, e-mail: Katherine.serrano@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of June 17, 2010 (75 FR 34463), FDA 
published a notice announcing a public meeting that is intended to 
create a forum for interested stakeholders to discuss the agency's 
oversight of laboratory developed tests. FDA announced in the notice 
that it is seeking input and requesting comments on this topic. The 
June 17, 2010, notice invited individuals interested in presenting to 
register by July 12, 2010. Registration to present at the public 
meeting is closed. All others are welcome to attend on a first-come, 
first-served basis.
    Because of greater than anticipated response for attending the 
public meeting, FDA is announcing in this notice a new location for the 
public meeting.

II. New Location for the Public Workshop

    The new location will be The Marriott Inn & Conference Center, 
University of Maryland University College (see ADDRESSES). Directions 
and information on parking, accommodations, and transportation options 
can be found at: http://www.marriott.com/hotels/travel/wasum-the-
marriott-inn-and-conference-center-university-of-maryland-university-
college/.

    Dated: July 7, 2010.
Nancy Stade,
Acting Associate Director for Regulations and Policy, Center for 
Devices and Radiological Health.
[FR Doc. 2010-16974 Filed 7-12-10; 8:45 am]
BILLING CODE 4160-01-S